Research and Markets: Monoclonal Antibodies Market in Breast Cancer to 2019 ... Business Wire (press release) The current market for breast cancer consists of five monoclonal Antibodies (mAbs), three of which are targeted at the Human Epidermal growth factor Receptor 2 (HER-2) protein. Four are aimed at improving overall survival in the metastatic setting, and ... |
